• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Therapeutic potential of gylcolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases

Research Project

Project/Area Number 14370169
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionNational Center of Neurology and Psychiatry

Principal Investigator

MIYAKE Sachiko  National Center of Neurology and Psychiatry (NCNP), National Institute of Neuroscience, Dept. of Immunology, Section Chief, 神経研究所・免疫研究部, 室長 (50266045)

Co-Investigator(Kenkyū-buntansha) YAMAMURA Takashi  National Center of Neurology and Psychiatry (NCNP), National Institute of Neuroscience, Dept. of Immunology, Director, 神経研究所・疾病研究第六部, 部長 (90231670)
Project Period (FY) 2002 – 2003
KeywordsNKT cells / Glycolipid / Autoimmune disease / Th2 cytokine / Collagen-induced arthritis / Type I diabetes / Experimental autoimmune encepahlomyelitis / Lupus model
Research Abstract

NKT cells emerge as important regulatory cells in autoimmune responses. Abnormalities in the numbers and functions of NKT cells have been observed in patients with autoimmune diseases as well as in a variety of mouse strains that are genetically predisposed for development of autoimmune diseases. We recently developed a synthetic glycolipid ligand OCH for NKT cells, an analogue of α-galactosylceramide (α-GC) with a truncated sphingosine chain. OCH induces a selective production of Th2 cytokines such as IL-4 and IL-10,whereas α-GC stimulates NKT cells to produce both IFN-γ and IL-4. We also demonstrated that administration of OCH inhibited experimental autoimmune encephalomyelitis (EAE). Here we show that administration of OCH, but not α-GC inhibits different Th1-mediated autoimmune disease models, collagen induced arthritis (CIA) and type I diabetes in NOD mouse by inducing Th2 bias of autoimmune T cells. Injection of OCH significantly suppressed EAE, CIA and diabetes clinically and histologically. The suppressive effect of OCH was not seen on EAE and CIA induced in CD1 knockout mouse, indicating OCH-mediated inhibition is dependent on NKT cells. Administration of anti-IL-4 or anti-IL-10 mAb abolished the inhibitory effect of OCH for CIA, suggesting Th2 cytokines secreted from NKT cells are critical for the suppression of CIA by OCH. Administration of OCH effectively inhibited CIA induced SJL mouse and diabetes in NOD mouse. SJL and NOD mice have been reported to be reduced in frequency and to have a defect in cytokine secretion from NKT cells upon activation as seen in the patients with autoimmune diseases, suggesting OCH is effective in these atuoimmune-prone mice. The lack of polymorphism of CD1d and cross-reactive response of mouse and human NKT cells to the same ligand indicates that targeting NKT cells with this ligand may be an attractive means for intervening in human autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.

  • Research Products

    (47 results)

All Other

All Publications (47 results)

  • [Publications] Rao N et al.: "Negative regulation of Lck by Cb1 ubiquitin ligase"Proc.Natl.Acad.Sci.USA. 99(6). 3794-3799 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Araki M, et al.: "Th2 bias of CD4+ natural killer T cells derived from multiple sclerosis in remission"Int.Immunol.. 15(2). 279-288 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyamoto K, et al.: "Heterozygous null mutation of myelin protein zero (P0) enhances susceptibility to autoimmune neuritis targeting P0 peptide"Eur.J.Immunol.. 33(3). 656-665 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koike F et al.: "Microarray analysis identifies interferon β-regulated genes in multiple sclerosis"J.Neuroimmunol.. 139(1-2). 109-118 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Bedoui S et al.: "Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis : NPY Y1 receptor-specific inhibition of autoreactive Th1 responses in vivo."J.Immunol.. 171(7). 3451-3458 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakamura T et al.: "CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged"J.Immunol.. 171(3). 1266-1271 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sranic AK et al.: "Another view of T cell antigen recognition : cooperative engagement of glycolipid antigens by Vα14Jα18 natural TCR"J.Immunol.. 171(9). 4539-4551 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Chiba A et al.: "Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide."Arthritis Rheum.. 50(1). 305-313 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oki S, et al.: "The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells"J.Clin.Inv.. In press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takahashi T, et al.: "The regulatory role for natural killer cells in the smoldering state of multiple sclerosis"Brain. In press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakai Y, et al.: "Natural killer T cells accelerate atherogeaesis a mice"Blood. In press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Satoh J-I, et al.: "Microarray analysis identifies an abberant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis."Neurobiol.Dis.. In press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyake S, et al.: "Potential of targeting natural killer T cells for the treatment of autoimmune diseases"Mod.Rheum.. In press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyake S, et al.: "Therapeutic potential of gylcolipid ligands for natural kilter (NK) T cells in the suppression of autoimmune diseases"CDT-IEMD. In press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Bedoui S, et al.: "More sympathy for aytoimmunity with neuropeptide Y?"Tremds Immunol.. In press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子: "NKT細胞と実験的自己免疫性脳脊髄炎"炎症と免疫. 10(5). 3-8 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子 他: "Cblによる免疫調節機構"臨床免疫. 38(1). 78-83 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子: "NKT細胞と自己免疫疾患制御"アレルギー・免疫. 19(9). 92-98 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山村隆 他: "NK・NKT細胞による実験的自己免疫性脳脊髄炎(EAE)の発症制御"タンパク質 核酸 酵素. 47(16). 2382-2387 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 宮本勝一 他: "糖脂質による自己免疫病の制御"感染 炎症 免疫. 32(3). 44-45 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子 他: "NKT細胞合成糖脂質リガンドによる関節炎の治療"臨床免疫. 40(1). 61-65 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子: "神経ペプチドと自己免疫疾患"Brain Medical. 15(4). 27-32 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山村隆 他: "多発性硬化症の進行を抑制する免疫細胞"Brain Medical. 15(4). 55-59 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子: "NKT細胞と自己免疫疾患"内科. 93(2). 213-216 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子: "免疫制御細胞と自己免疫疾患"Mol.Med.. 41(2). 177-182 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子: "ナチュラルキラーT細胞を標的とした多発性硬化症の糖脂質治療"医学のあゆみ. 208(5). 449-453 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子: "別冊医学のあゆみ"医歯薬出版株式会社. 33-38 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子 他: "Annual Review 免疫2003"中外医学社. 71-77 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 三宅幸子: "Annual Review 神経2004"中外医学社. 237-244 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyamoto K, Oka N, Kawasaki T, Miyake S, Yamamura T, Akiguchi I.: "New cyclooxygenase-2 inhibitors for treatment of experimental autoimmue neuritis."Muscle Nerve. 25(2). 280-282 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Gumperz J, Miyake S, Yamamura T, Brenner MB.: "Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining."J.Exp.Med.. 195(5). 625-636 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Rao N, Miyake S, Reddi AL, Douillard P, Ghosh AK, Dodge IL, Zhou P, Fernandes ND, Band H.: "Negative regulation of Lck by Cb1 ubiquitin ligase."Proc.Natl.Acad.Sci.USA.. 99(6). 3794-3799 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Araki M, Kondo T, Gumperz JE, Brenner N4B, Miyake S, Yamamura T.: "Th2 Bias of CD4^+ Natural Killer T Cells Derived from Multiple Sclerosis in Remission."Int.Immunol.. 15(2). 279-288 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyamoto K, Miyake S, Schachner M, Yamamura T.: "Heterozygous null mutation of myelin protein zero (P0) enhances susceptibility to autoimmune neuritis targeting P0 peptide."Eur.J.Immunol.. 33(3). 656-665 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koike F, Satoh J-i, Miyake S, Yamamoto T, Kawai M, Kikuchi S, Nomura K, Yokoyama K, Ota K, Kanda T, Fukazawa T, Yamamura T.: "Microarray analysis identifies interferon β-regulated genes in multiple sclerosis."J.Neuroimmunol.. 139(1-2). 109-118 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Bedoui S, Miyake S, Miyamoto K, Oki S, Lin Y, Kawamura N, Beck-Sickinger A, von Horsten S, Yamamura T.: "Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis : NPY Y1 receptor-specific inhibition of autoreactive Th1 responsese in vivo."J.Immunol.. 171(7). 3451-3458 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakamura T, Sonoda K-H, Faunce DE, Gumperz J, Yamamura T, Miyake S, Stein-Streilein J.: "CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site."J.Immunol.. 171(3). 1266-1271 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Stanic AK, Shashidharamurthy R, Bezbradica JS, Matsuki N, Yoshimura Y, Miyake S, Choi EY, Schell TD, Van Kaer L, Tevethia SS, Roopenian DC, Yamamura T, Joyce S.: "Another view of T cell antigen recognition : cooperative engagement of glycolipid antigens by Vα14Jα18 natural TCR."J.Immunol.. 171(9). 4539-4551 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, Miyake S.: "Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide."Arthritis Rheum.. 50(1). 305-313 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oki S, Chiba A, Yamamura T, Miyake S.: "The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells."J.Clin.Invest.. (In press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takahashi T, Miyake S, Endoh M, Yamamura T.: "The regulatory role for natural killer cells in the "smoldering" state of multiple sclerosis."Brain. (In press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakai Y, Iwabuchi K, Fujii S, Ishimori N, Dashtsoodol N, Watano K, Mishima T, Iwabuchi C, Kato K, Tanaka S, Bezbradica JS, Nakayama T, Tanigchi M, Miyake S, Yamamura T, Kitabatake A, Joyce S, Van Kaer L, Onoe K.: "Natural killer T cells accelerate atherogenesis in mice."Blood. (In press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Satoh J-i, Nakanishi M, Koike F, Miyake S, Yamamuto T, Kawai M, Kikuchi S, Nomura K, Yokoyama K, Ota K, Kanda T, Fukazawa T, Yamamura T.: "Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis."Neurobiol.Dis.. (In press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamamura T, Miyamoto K, Illes Z, Pal E, Araki M, Miyake S.: "Synthetic glycolipids as potential therapeutics for autoimmune disease."Curr.Topics.Medic.Chem.. 4(5). 561-567 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyake S, Chiba A, Yamamura T.: "Potential of targeting natural killer T cells for the treatment of autoimmune diseases."Mod.Rheum.. (In press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyake S, Yamamura T.: "Therapeutic potential of gylcolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases."CDT-IEMD.. (In press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Bedoui S, Miyake S, Yamamura T.: "More sympathy for autoimmunity with neuropeptide Y?"Trends Immunol.. (In press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi